Abhay Nayak is President of Global Diagnostics for Zoetis, the world leader in Animal Health and a Fortune 500 company. In this role, he leads a global organization focused on bringing diagnostic tools, insights and innovations to veterinary customers, pet owners and producers who care for animals. His areas of responsibility in this high-growth area for Zoetis include product management, commercial development, customer service, reference labs and U.S. sales and marketing teams.

Mr. Nayak joined Zoetis in 2018 and previously served as Executive Vice President, Head of Strategy, Accelerated Growth Businesses and Commercial Development. During his career at Zoetis, he has shaped the company’s global strategy and commercial development organizations; led, aligned and integrated various businesses focused on diagnostics, genetics, precision animal health, nutritional products and scientific wellness; and overseen the company’s customer experience, sustainability and chief medical officer programs.

Prior to joining Zoetis, Mr. Nayak was a consultant at McKinsey & Company where he advised leading pharmaceutical and medical device companies on crafting and executing global growth strategies. He started his career as an investment banker at Barclays in London, where he advised private equity clients on M&A, restructuring, and financing transactions in Europe, the Middle East, and Africa.

Mr. Nayak earned a bachelor’s degree in Economics from the University of Pennsylvania and an MBA from the Wharton School. He is also a CFA Charter holder.